FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Panel Backs Lumisight Breast Surgical Imaging

An FDA advisory committee votes 16-2 in support of approving a Lumicell NDA for Lumisight (pegulicianine), an optical imaging agent for use in patient...

latest-news-card-1
Medical Devices

Getinge Vasoview Hemopro 3 Cleared

FDA clears a Getinge 510(k) for the Vasoview Hemopro 3, a third-generation endoscopic vessel harvesting device.

latest-news-card-1
Human Drugs

Wegovy OKd for Reducing Cardiovascular Death

FDA approves Novo Nordisks weight loss drug Wegovy (semaglutide) injection for reducing the risk of cardiovascular death, heart attack and stroke in a...

latest-news-card-1
Human Drugs

FDA Delays Lilly Alzheimers Drug for Panel Review

FDA pushes back its review decision on Eli Lillys experimental Alzheimers drug donanemab by requiring an advisory committee to discuss the Phase 3 TRA...

latest-news-card-1
Human Drugs

Amylyx Mulls Withdrawing ALS Drug

Amylyx Pharmaceuticals considers withdrawing its amyotrophic lateral sclerosis drug Relyvrio (sodium phenylbutyrate and taurursodiol) after announcing...

latest-news-card-1
Federal Register

Lilly Requests EUA Revocation for Covid Combo

Federal Register notice: FDA revokes an Eli Lilly emergency use authorization for bamlanivimab and etesevimab administered together for treating Covid...

latest-news-card-1
Human Drugs

KVK Paying $3.5 Million in Guilty Plea

KVK Research and KVK Tech of Bucks County, PA, plead guilty to introducing adulterated drugs into interstate commerce and agree to pay a $1.5 million ...

latest-news-card-1
Human Drugs

Positive Phase 1 Data on New Novo Weight-Loss Drug

Novo Nordisk says its experimental weight-loss pill amycretin achieved a 13.1% weight loss in participants in a Phase 1 trial.

latest-news-card-1
Human Drugs

Accelerated Approval for Brukinsa for Some Lymphomas

FDA grants accelerated approval for BeiGenes Brukinsa used with Genentechs Gazyva to treat some follicular lymphomas.

latest-news-card-1
Human Drugs

Alliance for Regenerative Medicine AMT Concerns

The Alliance for Regenerative Medicine raises concerns about an FDA draft guidance on alternative manufacturing technologies.